These enhancers, associated with the upregulation of genes implicated in hematopoietic differentiation and leukemogenesis, suggest that PML-RARA-driven enhancer activity plays a pivotal role in APL biology, underscoring the importance of enhancer regulation in driving leukemia-specific transcriptional programs. The gene discussed is PML; the disease is acute promyelocytic leukemia.